Accelerating the Development of Biomarkers for Drug Safety: Workshop Summary
Book information
Description
Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a more focused and rational pathway to drug development. On October 24, 2008, the IOM's Forum on Drug Discovery, Development, and Translation held "Assessing and Accelerating Development of Biomarkers for Drug Safety," a one-day workshop, summarized in this volume, on the value of biomarkers in helping to determine drug safety during development.
Similar books
Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis: Workshop Summary
2013 · PDF
Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary
2011 · PDF
The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to Enhance Products from Discovery Through Approval: Workshop Summary
2010 · PDF
Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary
2009 · PDF
Addressing the Barriers to Pediatric Drug Development: Workshop Summary
2008 · PDF
An Evaluation of Radiation Exposure Guidance for Military Operations : Interim Report
1997 · PDF
Reliability of Medicare Hospital Discharge Records : Report of a Study
1977 · PDF
Reforming Physician Payment : Report of a Conference
1984 · PDF